About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

In a report released yesterday, Judah Frommer from Morgan Stanley maintained a Buy rating on Bicara Therapeutics Inc. (BCAX – Research Report), ...

Also known as Pembro, the drug - which stimulates the body's immune system to fight cancer cells - is licensed by the European Medicines Agency (EMA) mainly for advanced cancers. Ms Phelan ...